USA Fludeoxyglucose (18F) Radionuclide Injection Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Fludeoxyglucose (18F) radionuclide injection is radioactive substance used for diagnostic purpose with Positron Emission Tomography (PET).

    Advancement in radiopharmaceutical technologies along with more improve hardware and software of PET imaging are the primary factors driving the growth of Fludeoxyglucose (18F) Radionuclide Injection market. United States is expected to dominate the global Fludeoxyglucose (18F) Radionuclide Injection market due to high healthcare infrastructure. ter United States, Fludeoxyglucose (18F) Radionuclide Injection market is then followed by Europe and Asia-Pacific. Europe market is expected to grow due to rise in the number of manufacturing companies of Fludeoxyglucose (18F) Radionuclide Injection. In Asia-Pacific, India and China are expected to be major market owing to increasing geriatric population and cancer incidences.

    This report offers an overview of the market trends, drivers, and barriers with respect to the USA Fludeoxyglucose (18F) Radionuclide Injection market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Fludeoxyglucose (18F) Radionuclide Injection market. Detailed analysis of key players, along with key growth strategies adopted by Fludeoxyglucose (18F) Radionuclide Injection industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Shertech Laboratories

    • Queen's PET Imaging

    • Zevacor Pharma

    • Precision Nuclear

    • NCM USA Bronx

    • Triad Isotopes

    • Spectron MRC

    • Petnet Solutions

    By Type:

    • Cancer

    • Coronary Artery Disease

    • Others

    By End-User:

    • Hospitals

    • Clinics

    • Diagnostics Center

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Fludeoxyglucose (18F) Radionuclide Injection Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Fludeoxyglucose (18F) Radionuclide Injection Market Size and Growth Rate of Cancer from 2016 to 2027

      • 1.3.2 USA Fludeoxyglucose (18F) Radionuclide Injection Market Size and Growth Rate of Coronary Artery Disease from 2016 to 2027

      • 1.3.3 USA Fludeoxyglucose (18F) Radionuclide Injection Market Size and Growth Rate of Others from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Fludeoxyglucose (18F) Radionuclide Injection Market Size and Growth Rate of Hospitals from 2016 to 2027

      • 1.4.2 USA Fludeoxyglucose (18F) Radionuclide Injection Market Size and Growth Rate of Clinics from 2016 to 2027

      • 1.4.3 USA Fludeoxyglucose (18F) Radionuclide Injection Market Size and Growth Rate of Diagnostics Center from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Fludeoxyglucose (18F) Radionuclide Injection Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Fludeoxyglucose (18F) Radionuclide Injection Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Fludeoxyglucose (18F) Radionuclide Injection Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Fludeoxyglucose (18F) Radionuclide Injection Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Fludeoxyglucose (18F) Radionuclide Injection Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Fludeoxyglucose (18F) Radionuclide Injection by Major Types

      • 3.4.1 Market Size and Growth Rate of Cancer

      • 3.4.2 Market Size and Growth Rate of Coronary Artery Disease

      • 3.4.3 Market Size and Growth Rate of Others

    4 Segmentation of Fludeoxyglucose (18F) Radionuclide Injection Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Fludeoxyglucose (18F) Radionuclide Injection by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Fludeoxyglucose (18F) Radionuclide Injection in Hospitals

      • 4.4.2 Market Size and Growth Rate of Fludeoxyglucose (18F) Radionuclide Injection in Clinics

      • 4.4.3 Market Size and Growth Rate of Fludeoxyglucose (18F) Radionuclide Injection in Diagnostics Center

    5 Market Analysis by Regions

    • 5.1 USA Fludeoxyglucose (18F) Radionuclide Injection Production Analysis by Regions

    • 5.2 USA Fludeoxyglucose (18F) Radionuclide Injection Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Fludeoxyglucose (18F) Radionuclide Injection Landscape Analysis

    • 6.1 West USA Fludeoxyglucose (18F) Radionuclide Injection Landscape Analysis by Major Types

    • 6.2 West USA Fludeoxyglucose (18F) Radionuclide Injection Landscape Analysis by Major End-Users

    7 South USA Fludeoxyglucose (18F) Radionuclide Injection Landscape Analysis

    • 7.1 South USA Fludeoxyglucose (18F) Radionuclide Injection Landscape Analysis by Major Types

    • 7.2 South USA Fludeoxyglucose (18F) Radionuclide Injection Landscape Analysis by Major End-Users

    8 Middle West USA Fludeoxyglucose (18F) Radionuclide Injection Landscape Analysis

    • 8.1 Middle West USA Fludeoxyglucose (18F) Radionuclide Injection Landscape Analysis by Major Types

    • 8.2 Middle West USA Fludeoxyglucose (18F) Radionuclide Injection Landscape Analysis by Major End-Users

    9 Northeast USA Fludeoxyglucose (18F) Radionuclide Injection Landscape Analysis

    • 9.1 Northeast USA Fludeoxyglucose (18F) Radionuclide Injection Landscape Analysis by Major Types

    • 9.2 Northeast USA Fludeoxyglucose (18F) Radionuclide Injection Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Shertech Laboratories

        • 10.1.1 Shertech Laboratories Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Queen's PET Imaging

        • 10.2.1 Queen's PET Imaging Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Zevacor Pharma

        • 10.3.1 Zevacor Pharma Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Precision Nuclear

        • 10.4.1 Precision Nuclear Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 NCM USA Bronx

        • 10.5.1 NCM USA Bronx Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Triad Isotopes

        • 10.6.1 Triad Isotopes Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Spectron MRC

        • 10.7.1 Spectron MRC Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Petnet Solutions

        • 10.8.1 Petnet Solutions Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Fludeoxyglucose (18F) Radionuclide Injection Market Size and Growth Rate of Cancer from 2016 to 2027

    • Figure USA Fludeoxyglucose (18F) Radionuclide Injection Market Size and Growth Rate of Coronary Artery Disease from 2016 to 2027

    • Figure USA Fludeoxyglucose (18F) Radionuclide Injection Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Fludeoxyglucose (18F) Radionuclide Injection Market Size and Growth Rate of Hospitals from 2016 to 2027

    • Figure USA Fludeoxyglucose (18F) Radionuclide Injection Market Size and Growth Rate of Clinics from 2016 to 2027

    • Figure USA Fludeoxyglucose (18F) Radionuclide Injection Market Size and Growth Rate of Diagnostics Center from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Fludeoxyglucose (18F) Radionuclide Injection Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Fludeoxyglucose (18F) Radionuclide Injection Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Fludeoxyglucose (18F) Radionuclide Injection Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Fludeoxyglucose (18F) Radionuclide Injection Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Fludeoxyglucose (18F) Radionuclide Injection Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Fludeoxyglucose (18F) Radionuclide Injection

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Fludeoxyglucose (18F) Radionuclide Injection by Different Types from 2016 to 2027

    • Table Consumption Share of Fludeoxyglucose (18F) Radionuclide Injection by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Cancer

    • Figure Market Size and Growth Rate of Coronary Artery Disease

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Fludeoxyglucose (18F) Radionuclide Injection by Different End-Users from 2016 to 2027

    • Table Consumption Share of Fludeoxyglucose (18F) Radionuclide Injection by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Hospitals

    • Figure Market Size and Growth Rate of Clinics

    • Figure Market Size and Growth Rate of Diagnostics Center

    • Table USA Fludeoxyglucose (18F) Radionuclide Injection Production by Regions

    • Table USA Fludeoxyglucose (18F) Radionuclide Injection Production Share by Regions

    • Figure USA Fludeoxyglucose (18F) Radionuclide Injection Production Share by Regions in 2016

    • Figure USA Fludeoxyglucose (18F) Radionuclide Injection Production Share by Regions in 2021

    • Figure USA Fludeoxyglucose (18F) Radionuclide Injection Production Share by Regions in 2027

    • Table USA Fludeoxyglucose (18F) Radionuclide Injection Consumption by Regions

    • Table USA Fludeoxyglucose (18F) Radionuclide Injection Consumption Share by Regions

    • Figure USA Fludeoxyglucose (18F) Radionuclide Injection Consumption Share by Regions in 2016

    • Figure USA Fludeoxyglucose (18F) Radionuclide Injection Consumption Share by Regions in 2021

    • Figure USA Fludeoxyglucose (18F) Radionuclide Injection Consumption Share by Regions in 2027

    • Table West USA Fludeoxyglucose (18F) Radionuclide Injection Consumption by Types from 2016 to 2027

    • Table West USA Fludeoxyglucose (18F) Radionuclide Injection Consumption Share by Types from 2016 to 2027

    • Figure West USA Fludeoxyglucose (18F) Radionuclide Injection Consumption Share by Types in 2016

    • Figure West USA Fludeoxyglucose (18F) Radionuclide Injection Consumption Share by Types in 2021

    • Figure West USA Fludeoxyglucose (18F) Radionuclide Injection Consumption Share by Types in 2027

    • Table West USA Fludeoxyglucose (18F) Radionuclide Injection Consumption by End-Users from 2016 to 2027

    • Table West USA Fludeoxyglucose (18F) Radionuclide Injection Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Fludeoxyglucose (18F) Radionuclide Injection Consumption Share by End-Users in 2016

    • Figure West USA Fludeoxyglucose (18F) Radionuclide Injection Consumption Share by End-Users in 2021

    • Figure West USA Fludeoxyglucose (18F) Radionuclide Injection Consumption Share by End-Users in 2027

    • Table South USA Fludeoxyglucose (18F) Radionuclide Injection Consumption by Types from 2016 to 2027

    • Table South USA Fludeoxyglucose (18F) Radionuclide Injection Consumption Share by Types from 2016 to 2027

    • Figure South USA Fludeoxyglucose (18F) Radionuclide Injection Consumption Share by Types in 2016

    • Figure South USA Fludeoxyglucose (18F) Radionuclide Injection Consumption Share by Types in 2021

    • Figure South USA Fludeoxyglucose (18F) Radionuclide Injection Consumption Share by Types in 2027

    • Table South USA Fludeoxyglucose (18F) Radionuclide Injection Consumption by End-Users from 2016 to 2027

    • Table South USA Fludeoxyglucose (18F) Radionuclide Injection Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Fludeoxyglucose (18F) Radionuclide Injection Consumption Share by End-Users in 2016

    • Figure South USA Fludeoxyglucose (18F) Radionuclide Injection Consumption Share by End-Users in 2021

    • Figure South USA Fludeoxyglucose (18F) Radionuclide Injection Consumption Share by End-Users in 2027

    • Table Middle West USA Fludeoxyglucose (18F) Radionuclide Injection Consumption by Types from 2016 to 2027

    • Table Middle West USA Fludeoxyglucose (18F) Radionuclide Injection Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Fludeoxyglucose (18F) Radionuclide Injection Consumption Share by Types in 2016

    • Figure Middle West USA Fludeoxyglucose (18F) Radionuclide Injection Consumption Share by Types in 2021

    • Figure Middle West USA Fludeoxyglucose (18F) Radionuclide Injection Consumption Share by Types in 2027

    • Table Middle West USA Fludeoxyglucose (18F) Radionuclide Injection Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Fludeoxyglucose (18F) Radionuclide Injection Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Fludeoxyglucose (18F) Radionuclide Injection Consumption Share by End-Users in 2016

    • Figure Middle West USA Fludeoxyglucose (18F) Radionuclide Injection Consumption Share by End-Users in 2021

    • Figure Middle West USA Fludeoxyglucose (18F) Radionuclide Injection Consumption Share by End-Users in 2027

    • Table Northeast USA Fludeoxyglucose (18F) Radionuclide Injection Consumption by Types from 2016 to 2027

    • Table Northeast USA Fludeoxyglucose (18F) Radionuclide Injection Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Fludeoxyglucose (18F) Radionuclide Injection Consumption Share by Types in 2016

    • Figure Northeast USA Fludeoxyglucose (18F) Radionuclide Injection Consumption Share by Types in 2021

    • Figure Northeast USA Fludeoxyglucose (18F) Radionuclide Injection Consumption Share by Types in 2027

    • Table Northeast USA Fludeoxyglucose (18F) Radionuclide Injection Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Fludeoxyglucose (18F) Radionuclide Injection Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Fludeoxyglucose (18F) Radionuclide Injection Consumption Share by End-Users in 2016

    • Figure Northeast USA Fludeoxyglucose (18F) Radionuclide Injection Consumption Share by End-Users in 2021

    • Figure Northeast USA Fludeoxyglucose (18F) Radionuclide Injection Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Shertech Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shertech Laboratories

    • Figure Sales and Growth Rate Analysis of Shertech Laboratories

    • Figure Revenue and Market Share Analysis of Shertech Laboratories

    • Table Product and Service Introduction of Shertech Laboratories

    • Table Company Profile and Development Status of Queen's PET Imaging

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Queen's PET Imaging

    • Figure Sales and Growth Rate Analysis of Queen's PET Imaging

    • Figure Revenue and Market Share Analysis of Queen's PET Imaging

    • Table Product and Service Introduction of Queen's PET Imaging

    • Table Company Profile and Development Status of Zevacor Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Zevacor Pharma

    • Figure Sales and Growth Rate Analysis of Zevacor Pharma

    • Figure Revenue and Market Share Analysis of Zevacor Pharma

    • Table Product and Service Introduction of Zevacor Pharma

    • Table Company Profile and Development Status of Precision Nuclear

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Precision Nuclear

    • Figure Sales and Growth Rate Analysis of Precision Nuclear

    • Figure Revenue and Market Share Analysis of Precision Nuclear

    • Table Product and Service Introduction of Precision Nuclear

    • Table Company Profile and Development Status of NCM USA Bronx

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of NCM USA Bronx

    • Figure Sales and Growth Rate Analysis of NCM USA Bronx

    • Figure Revenue and Market Share Analysis of NCM USA Bronx

    • Table Product and Service Introduction of NCM USA Bronx

    • Table Company Profile and Development Status of Triad Isotopes

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Triad Isotopes

    • Figure Sales and Growth Rate Analysis of Triad Isotopes

    • Figure Revenue and Market Share Analysis of Triad Isotopes

    • Table Product and Service Introduction of Triad Isotopes

    • Table Company Profile and Development Status of Spectron MRC

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Spectron MRC

    • Figure Sales and Growth Rate Analysis of Spectron MRC

    • Figure Revenue and Market Share Analysis of Spectron MRC

    • Table Product and Service Introduction of Spectron MRC

    • Table Company Profile and Development Status of Petnet Solutions

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Petnet Solutions

    • Figure Sales and Growth Rate Analysis of Petnet Solutions

    • Figure Revenue and Market Share Analysis of Petnet Solutions

    • Table Product and Service Introduction of Petnet Solutions


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.